U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07596901) titled 'Study of Aritinercept in Patients With Generalized Myasthenia Gravis' on May 13.
Brief Summary: This clinical study will enroll patients with generalized myasthenia gravis (gMG). The goal of this clinical study is to assess the safety, tolerability, effectiveness, pharmacokinetics (how the body processes the drug) and pharmacodynamics (how the drug affects the body) of aritinercept.
Study Start Date: April 22
Study Type: INTERVENTIONAL
Condition:
Myasthenia Gravis, Generalized
Intervention:
DRUG: Aritinercept
For subcutaneous injection
OTHER: Placebo
For subcutaneous injection
Recruitment Status: RECRUITING
Sponsor: Aurini...